drugset / Trial / NCT00979901
Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the ability of montelukast to improve the signs and symptoms of seasonal allergic rhinitis compared with loratadine and placebo.
Timeline
- Start
- 2000-03
- Primary completion
- 2000-05
- Completion
- 2000-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Loratadine | Small molecule | 10 mg | Oral |
| Subject | Montelukast | Other / unclassified | 10 mg | Oral |